MYC and Hyperammonemia: Being the actual therapeutic options to treat hyperammonemia unsatisfactory,[49, 51] the discovery of the β‐catenin/c‐Myc axis involvement in autophagy regulation by ammonia opens new landscapes for the development of novel therapeutic targets and novel treatment options.